Stock EZZ EZZ LIFE SCIENCE HOLDINGS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials EZZ Life Science Holdings Limited

Equities

EZZ

AU0000130569

Pharmaceuticals

Market Closed - Australian S.E.
Other stock markets
 01:51:27 2024-05-21 am EDT 		5-day change 1st Jan Change
0.97 AUD +3.19% Intraday chart for EZZ Life Science Holdings Limited -8.49% +49.23%
May. 07 EZZ Life Science Declares Fully Franked Interim Dividend MT
Apr. 26 EZZ Life's Receipts from Customers Up 111% in Fiscal Q3 MT

Valuation

Fiscal Period: June 2021 2022 2023
Capitalization 1 18.69 13.26 21.35
Enterprise Value (EV) 1 9.915 2.895 8
P/E ratio 7.44 x 10 x 5.88 x
Yield 1.01% 1.45% 1.96%
Capitalization / Revenue 0.84 x 0.88 x 0.57 x
EV / Revenue 0.44 x 0.19 x 0.22 x
EV / EBITDA 3.59 x 1.61 x 1.71 x
EV / FCF -220,439,484 x 1,800,868 x 2,379,441 x
FCF Yield -0% 0% 0%
Price to Book 1.85 x 1.16 x 1.46 x
Nbr of stocks (in thousands) 42,000 42,760 42,705
Reference price 2 0.4450 0.3100 0.5000
Announcement Date 9/30/21 9/30/22 9/28/23
1AUD in Million2AUD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: Juni 2019 2020 2021 2022 2023
Net sales 1 11.19 17.97 22.29 15.02 37.16
EBITDA 1 1.181 2.179 2.765 1.799 4.678
EBIT 1 1.177 2.156 2.748 1.784 4.659
Operating Margin 10.52% 12% 12.33% 11.88% 12.54%
Earnings before Tax (EBT) 1 1.177 2.15 2.737 1.78 4.901
Net income 1 0.8238 1.586 2.031 1.312 3.63
Net margin 7.36% 8.83% 9.11% 8.74% 9.77%
EPS - - 0.0598 0.0309 0.0850
Free Cash Flow - 2.554 -0.045 1.608 3.362
FCF margin - 14.21% -0.2% 10.7% 9.05%
FCF Conversion (EBITDA) - 117.19% - 89.37% 71.87%
FCF Conversion (Net income) - 161.01% - 122.5% 92.63%
Dividend per Share - - 0.004500 0.004500 0.009800
Announcement Date 3/1/21 3/1/21 9/30/21 9/30/22 9/28/23
1AUD in Million
Estimates

Balance Sheet Analysis

Fiscal Period: Juni 2019 2020 2021 2022 2023
Net Debt 1 - - - - -
Net Cash position 1 0.41 3.14 8.77 10.4 13.4
Leverage (Debt/EBITDA) - - - - -
Free Cash Flow - 2.55 -0.04 1.61 3.36
ROE (net income / shareholders' equity) - 98.1% 32.4% 12.2% 28%
ROA (Net income/ Total Assets) - 29.6% 18.8% 8.48% 18.3%
Assets 1 - 5.356 10.77 15.48 19.88
Book Value Per Share - - 0.2400 0.2700 0.3400
Cash Flow per Share - - 0.2100 0.2400 0.3200
Capex 1 0 0.09 0.01 0.01 0.1
Capex / Sales 0.02% 0.5% 0.03% 0.04% 0.27%
Announcement Date 3/1/21 3/1/21 9/30/21 9/30/22 9/28/23
1AUD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
EZZ LIFE SCIENCE HOLDINGS LIMITED Stock EZZ Life Science Holdings Limited
+49.23% 27.88M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+34.35% 705B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+31.36% 583B
JOHNSON & JOHNSON Stock Johnson & Johnson
-3.49% 364B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.15% 332B
ABBVIE INC. Stock AbbVie Inc.
+6.19% 291B
ASTRAZENECA PLC Stock AstraZeneca PLC
+14.66% 238B
ROCHE HOLDING AG Stock Roche Holding AG
-3.72% 210B
NOVARTIS AG Stock Novartis AG
+10.06% 209B
AMGEN INC. Stock Amgen Inc.
+9.21% 169B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. EZZ Stock
  4. Financials EZZ Life Science Holdings Limited
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW